Quick diagnostic sprints deliver measurable results in weeks, not years, helping manufacturers prove AI value before ...
Araclon Biotech has provided early evidence that its Alzheimer’s disease vaccine is effective, linking the candidate to a 38% slowdown in disease progression compared to placebo in an exploratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback